Overcoming Barriers to the Effective Management of Severe Asthma in Italy

References

• Global Initiative for Asthma. 2020 GINA report, global strategy for asthma management and prevention; 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf. Accessed October 13, 2020.
   Google Scholar
• Global Asthma Network. The global asthma report2020; 2020. Available from: www.ginasthma.org. Accessed October 13, 2020.
   Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013
   PubMed Web of Science ®Google Scholar
• Hekking PP, Wener RR, Amelink M, et al. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896–902. doi:10.1016/j.jaci.2014.08.042
   PubMed Web of Science ®Google Scholar
• Larsson K, Stallberg B, Lisspers K, et al. Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR). Respir Res. 2018;19(1):12. doi:10.1186/s12931-018-0719-x
   PubMed Web of Science ®Google Scholar
• Taylor DR, Bateman ED, Boulet LP, et al. A new perspective on concepts of asthma severity and control. Eur Respir J. 2008;32(3):545–554. doi:10.1183/09031936.00155307
   PubMed Web of Science ®Google Scholar
• Song WJ, Lee JH, Kang Y, et al. Future risks in patients with severe asthma. Allergy Asthma Immunol Res. 2019;11(6):763–778. doi:10.4168/aair.2019.11.6.763
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Li Q, et al. Burden of chronic oral corticosteroid use by adults with persistent asthma. J Allergy Clin Immunol Pract. 2017;5(4):1050–1060, e1059. doi:10.1016/j.jaip.2016.12.023
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Duh MS, Lafeuille MH, et al. Burden of systemic glucocorticoid-related complications in severe asthma. Curr Med Res Opin. 2017;33(1):57–65. doi:10.1080/03007995.2016.1233101
   PubMed Web of Science ®Google Scholar
• Foster JM, McDonald VM, Guo M, et al. “I have lost in every facet of my life”: the hidden burden of severe asthma. Eur Respir J. 2017;50(3):1700765. doi:10.1183/13993003.00765-2017
   PubMed Web of Science ®Google Scholar
• Eassey D, Reddel HK, Foster JM, et al. I’ve said I wish I was dead, you’d be better off without me”: a systematic review of people’s experiences of living with severe asthma. J Asthma. 2019;56(3):311–322. doi:10.1080/02770903.2018.1452034
   PubMed Web of Science ®Google Scholar
• Antonicelli L, Bucca C, Neri M, et al. Asthma severity and medical resource utilisation. Eur Respir J. 2004;23(5):723–729. doi:10.1183/09031936.04.00004904
   PubMed Web of Science ®Google Scholar
• Canonica GW, Colombo GL, Bruno GM, et al. Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. World Allergy Organ J. 2019;12(1):100007. doi:10.1016/j.waojou.2018.12.001
   PubMed Web of Science ®Google Scholar
• Chung LP, Upham JW, Bardin PG, et al. Rational oral corticosteroid use in adult severe asthma: a narrative review. Respirology. 2020;25(2):161–172. doi:10.1111/resp.13730
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. 2014 GINA report, global strategy for asthma management and prevention; 2014. Available from: https://ginasthma.org/wp-content/uploads/2019/01/2014-GINA.pdf. Accessed October 13, 2020.
   Google Scholar
• Global Initiative for Asthma. 2019 GINA report, global strategy for asthma management and prevention; 2019. Available from: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf. Accessed October 13, 2020.
   Google Scholar
• Price DB, Trudo F, Voorham J, et al. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. 2018;11:193–204. doi:10.2147/JAA.S176026
   PubMed Web of Science ®Google Scholar
• Volmer T, Effenberger T, Trautner C, et al. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature. Eur Respir J. 2018;52(4):1800703. doi:10.1183/13993003.00703-2018
   PubMed Web of Science ®Google Scholar
• Bleecker ER, Menzies-Gow AN, Price DB, et al. Systematic literature review of systemic corticosteroid use for asthma management. Am J Respir Crit Care Med. 2019;201(3):276–293. doi:10.1164/rccm.201904-0903SO
   Web of Science ®Google Scholar
• Heffler E, Blasi F, Latorre M, et al. The Severe Asthma Network in Italy: findings and perspectives. J Allergy Clin Immunol Pract. 2019;7(5):1462–1468. doi:10.1016/j.jaip.2018.10.016
   PubMed Web of Science ®Google Scholar
• Vetrano DL, Zucchelli A, Bianchini E, et al. Patterns of oral corticosteroids use in primary care patients with severe asthma. Respir Med. 2020;166:105946. doi:10.1016/j.rmed.2020.105946
   PubMed Web of Science ®Google Scholar
• D’Amato G, Vitale C, Molino A, et al. Asthma-related deaths. Multidiscip Respir Med. 2016;11:37. doi:10.1186/s40248-016-0073-0
   PubMed Web of Science ®Google Scholar
• Price D, Bjermer L, Bergin DA, et al. Asthma referrals: a key component of asthma management that needs to be addressed. J Asthma Allergy. 2017;10:209–223. doi:10.2147/JAA.S134300
   PubMed Web of Science ®Google Scholar
• Levy ML, Andrews R, Buckingham R, et al. Why asthma still kills. The National Review of Asthma Deaths (NRAD); 2014. Available from: https://www.rcplondon.ac.uk/file/868/download. Accessed October 13, 2020.
   Google Scholar
• Bourdin A, Molinari N, Vachier I, et al. Mortality: a neglected outcome in OCS-treated severe asthma. Eur Respir J. 2017;50(5):1701486. doi:10.1183/13993003.01486-2017
   PubMed Web of Science ®Google Scholar
• Ekström M, Nwaru BI, Hasvold P, et al. Oral corticosteroid use, morbidity and mortality in asthma: a nationwide prospective cohort study in Sweden. Allergy. 2019;74(11):2181–2190. doi:10.1111/all.13874
   PubMed Web of Science ®Google Scholar
• Menzies-Gow A, Canonica GW, Winders TA, et al. A charter to improve patient care in severe asthma. Adv Ther. 2018;35(10):1485–1496. doi:10.1007/s12325-018-0777-y
   PubMed Web of Science ®Google Scholar
• Baiardini I, Sicuro F, Balbi F, et al. Psychological aspects in asthma: do psychological factors affect asthma management? Asthma Res Pract. 2015;1:7. doi:10.1186/s40733-015-0007-1
   PubMedGoogle Scholar
• Byrnes PD. Why haven’t I changed that? Therapeutic inertia in general practice. Aust Fam Physician. 2011;40(1–2):24–28.
   Google Scholar
• Chiu KC, Boonsawat W, Cho SH, et al. Patients’ beliefs and behaviors related to treatment adherence in patients with asthma requiring maintenance treatment in Asia. J Asthma. 2014;51(6):652–659. doi:10.3109/02770903.2014.898772
   PubMed Web of Science ®Google Scholar
• Harris DA, Mainardi A, Iyamu O, et al. Improving the asthma disparity gap with legal advocacy? A qualitative study of patient-identified challenges to improve social and environmental factors that contribute to poorly controlled asthma. J Asthma. 2018;55(8):924–932. doi:10.1080/02770903.2017.1373393
   PubMed Web of Science ®Google Scholar
• Lingner H, Burger B, Kardos P, et al. What patients really think about asthma guidelines: barriers to guideline implementation from the patients’ perspective. BMC Pulm Med. 2017;17(1):13. doi:10.1186/s12890-016-0346-6
   PubMed Web of Science ®Google Scholar
• Majellano EC, Clark VL, Winter NA, et al. Approaches to the assessment of severe asthma: barriers and strategies. J Asthma Allergy. 2019;12:235–251. doi:10.2147/JAA.S178927
   PubMed Web of Science ®Google Scholar
• Larenas-Linnemann D, Fernandez-Vega M, Rodriguez-Gonzalez M, et al. An online survey detected knowledge gaps and cost-saving opportunities in asthma maintenance treatment among allergists, pulmonologists, ENTs and primary care. World Allergy Organ J. 2019;12(12):100084. doi:10.1016/j.waojou.2019.100084
   Web of Science ®Google Scholar
• Pavord ID. Oral corticosteroid-dependent asthma: current knowledge and future needs. Curr Opin Pulm Med. 2019;25(1):51–58. doi:10.1097/MCP.0000000000000541
   PubMed Web of Science ®Google Scholar
• Bel EH, Wenzel SE, Thompson PJ, et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med. 2014;371(13):1189–1197. doi:10.1056/NEJMoa1403291
   PubMed Web of Science ®Google Scholar
• Nair P, Wenzel S, Rabe KF, et al. Oral glucocorticoid-sparing effect of benralizumab in severe asthma. N Engl J Med. 2017;376(25):2448–2458. doi:10.1056/NEJMoa1703501
   PubMed Web of Science ®Google Scholar
• Rabe KF, Nair P, Brusselle G, et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med. 2018;378(26):2475–2485. doi:10.1056/NEJMoa1804093
   PubMed Web of Science ®Google Scholar
• Bourdin A, Shaw D, Menzies-Gow A, et al. Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma. J Asthma. 2019;1–9.
   Web of Science ®Google Scholar
• Heffler E, Bagnasco D, Canonica GW. Strategies to reduce corticosteroid-related adverse events in asthma. Curr Opin Allergy Clin Immunol. 2019;19(1):61–67. doi:10.1097/ACI.0000000000000493
   PubMed Web of Science ®Google Scholar
• Papi A, Blasi F, Canonica GW, et al. Treatment strategies for asthma: reshaping the concept of asthma management. Allergy Asthma Clin Immunol. 2020;16:75. doi:10.1186/s13223-020-00472-8
   PubMed Web of Science ®Google Scholar
• Kritikos V, Price D, Papi A, et al. A multinational observational study identifying primary care patients at risk of overestimation of asthma control. NPJ Prim Care Respir Med. 2019;29(1):43. doi:10.1038/s41533-019-0156-4
   PubMed Web of Science ®Google Scholar
• Shaker MS, Oppenheimer J, Grayson M, et al. COVID-19: pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract. 2020;8(5):1477–1488, e1475. doi:10.1016/j.jaip.2020.03.012
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. COVID-19: GINA answers to frequently asked questions on asthma management; 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/03/Final-COVID-19-answers-to-frequent-questions-25.3.2020-1.pdf. Accessed October 13, 2020.
   Google Scholar
• National Institute for Health and Care Excellence. COVID-19 rapid guideline: severe asthma; 2020. Available from: https://www.nice.org.uk/guidance/ng166/resources/covid19-rapid-guideline-severe-asthma-pdf-66141904108741. Accessed October 13, 2020.
   Google Scholar
• Associazione Allergologi Immunologi Italiani Territoriali e Ospedalieri. Useful information for allergic patients in times of coronavirus [in Italian]; 2020. Available from: https://docs.biomedia.net/2020/aaiito/Comunicato%20Covid19.pdf. Accessed October 13, 2020.
   Google Scholar
• Societa’ Italiana di Allergologia AeIC. SIAAIC address document for respiratory allergic patients and the Centers for Allergy, Asthma and Immunology Clinic; 2020. Available from: http://www.siaaic.org/wp-content/uploads/2020/05/Documento-di-Indirizzo-SIAAIC-v2.pdf. Accessed October 13, 2020.
   Google Scholar
• Malipiero G, Paoletti G, Puggioni F, et al. An academic allergy unit during COVID-19 pandemic in Italy. J Allergy Clin Immunol. 2020;146(1):227. doi:10.1016/j.jaci.2020.04.003
   Web of Science ®Google Scholar